MacroGenics Inc (MGNX) stock
MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.05−0.12 (-5.53%)
Close on Nov 17, 2026Market cap $130.59MP/E –Yield –
MacroGenics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
MacroGenics's price to sales ratio was 0.9× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.5× to 19.0×, with a median of 2.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.9× | −0.0 |
| 2025 | Dec 31, 2025 | 0.9× | −0.5 |
| 2024 | Dec 31, 2024 | 1.4× | −3.5 |
| 2023 | Dec 29, 2023 | 4.9× | +0.5 |
| 2022 | Dec 30, 2022 | 4.4× | −4.0 |
| 2021 | Dec 31, 2021 | 8.5× | −8.1 |
| 2020 | Dec 31, 2020 | 16.6× | +6.9 |
| 2019 | Dec 31, 2019 | 9.7× | +7.0 |
| 2018 | Dec 31, 2018 | 2.7× | −63.9 |
| 2017 | Dec 29, 2017 | 66.7× | +59.2 |
| 2016 | Dec 30, 2016 | 7.5× | −3.3 |
| 2015 | Dec 31, 2015 | 10.8× | −4.9 |
| 2014 | Dec 31, 2014 | 15.7× | +14.6 |
| 2013 | Dec 31, 2013 | 1.1× | – |
See a number that looks wrong?